Literature DB >> 9266630

Immune responses throughout hepatitis C virus (HCV) infection: HCV from the immune system point of view.

S Abrignani1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9266630     DOI： 10.1007/bf00945024

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN： 0344-4325


× No keyword cloud information.
  40 in total

1.  Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo.

Authors:  H Pircher; D Moskophidis; U Rohrer; K Bürki; H Hengartner; R M Zinkernagel
Journal:  Nature       Date:  1990-08-16       Impact factor: 49.962

Review 2.  Antigenicity: some molecular aspects.

Authors:  M Sela
Journal:  Science       Date:  1969-12-12       Impact factor: 47.728

3.  Prevention of post-transfusion non-A, non-B hepatitis by non-specific immunoglobulin in heart surgery patients.

Authors:  A Sánchez-Quijano; J A Pineda; E Lissen; M Leal; M A Díaz-Torres; F García De Pesquera; F Rivera; R Castro; J Muñoz
Journal:  Lancet       Date:  1988-06-04       Impact factor: 79.321

4.  Hepatitis B immune globulin to prevent non-A, non-B post-transfusion hepatitis.

Authors:  U Sugg; W Schneider; H E Hoffmeister; C Huth; W Stephan; R Lissner; W Haase
Journal:  Lancet       Date:  1985-02-16       Impact factor: 79.321

5.  T-lymphocyte response to hepatitis C virus in different clinical courses of infection.

Authors:  P Botarelli; M R Brunetto; M A Minutello; P Calvo; D Unutmaz; A J Weiner; Q L Choo; J R Shuster; G Kuo; F Bonino
Journal:  Gastroenterology       Date:  1993-02       Impact factor: 22.682

6.  A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells.

Authors:  D Rosa; S Campagnoli; C Moretto; E Guenzi; L Cousens; M Chin; C Dong; A J Weiner; J Y Lau; Q L Choo; D Chien; P Pileri; M Houghton; S Abrignani
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

7.  Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.

Authors:  J Y Lau; G L Davis; J Kniffen; K P Qian; M S Urdea; C S Chan; M Mizokami; P D Neuwald; J C Wilber
Journal:  Lancet       Date:  1993-06-12       Impact factor: 79.321

8.  Lymphocyte specificity to protein antigens. V. Conformational dependence of activation of cytochrome c-specific T cells.

Authors:  Y Buchmüller; G Corradin
Journal:  Eur J Immunol       Date:  1982-05       Impact factor: 5.532

9.  Stimulation of human naive and memory T helper cells with bacterial superantigen. Naive CD4+45RA+ T cells require a costimulatory signal mediated through the LFA-1/ICAM-1 pathway.

Authors:  H Fischer; A Gjörloff; G Hedlund; H Hedman; E Lundgren; T Kalland; H O Sjögren; M Dohlsten
Journal:  J Immunol       Date:  1992-04-01       Impact factor: 5.422

10.  Differences in antigen presentation to MHC class I-and class II-restricted influenza virus-specific cytolytic T lymphocyte clones.

Authors:  L A Morrison; A E Lukacher; V L Braciale; D P Fan; T J Braciale
Journal:  J Exp Med       Date:  1986-04-01       Impact factor: 14.307
View more
  8 in total

1.  Increased hepatitis C virus (HCV)-specific CD4+CD25+ regulatory T lymphocytes and reduced HCV-specific CD4+ T cell response in HCV-infected patients with normal versus abnormal alanine aminotransferase levels.

Authors:  F Bolacchi; A Sinistro; C Ciaprini; F Demin; M Capozzi; F C Carducci; C M J Drapeau; G Rocchi; A Bergamini
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

2.  The entire core protein of HCV JFH1 is required for efficient formation of infectious JFH1 pseudoparticles.

Authors:  Priyanka Shukla; Kristina N Faulk; Suzanne U Emerson
Journal:  J Med Virol       Date:  2010-05       Impact factor: 2.327

3.  Usefulness of a liver biopsy in the evaluation of patients with elevated ALT values and serological markers of hepatitis viral infection: an AIGO study.

Authors:  A Andriulli; V Festa; G Leandro; M Rizzetto
Journal:  Dig Dis Sci       Date:  2001-07       Impact factor: 3.199

4.  Evidence for prostaglandin-producing supressor cells in HCV patients with normal ALT.

Authors:  Rui Marinho; Ruth Pinto; Maria Livia Santos; MouraMiguelCarneiro de
Journal:  Dig Dis Sci       Date:  2002-03       Impact factor: 3.199

5.  Association of colonic regulatory T cells with hepatitis C virus pathogenesis and liver pathology.

Authors:  Helal F Hetta; Mohamed A Mekky; Nasr K Khalil; Wegdan A Mohamed; Mohamed A El-Feky; Shabaan H Ahmed; Enas A Daef; Mahmoud I Nassar; Ahmed Medhat; Kenneth E Sherman; Mohamed Tarek M Shata
Journal:  J Gastroenterol Hepatol       Date:  2015-10       Impact factor: 4.029

6.  Viral persistence, antibody to E1 and E2, and hypervariable region 1 sequence stability in hepatitis C virus-inoculated chimpanzees.

Authors:  S E Bassett; D L Thomas; K M Brasky; R E Lanford
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

Review 7.  HIV and co-infections.

Authors:  Christina C Chang; Megan Crane; Jingling Zhou; Michael Mina; Jeffrey J Post; Barbara A Cameron; Andrew R Lloyd; Anthony Jaworowski; Martyn A French; Sharon R Lewin
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

8.  Association between IL28B rs12979860 single nucleotide polymorphism and the frequency of colonic Treg in chronically HCV-infected patients.

Authors:  Minesh Mehta; Helal F Hetta; Enass A Abdel-Hameed; Susan D Rouster; MdMonir Hossain; Mohamed A Mekky; Nasr K Khalil; Wegdan A Mohamed; Mohamed A El-Feky; Shabaan H Ahmed; Enas A Daef; Mohamed A El-Mokhtar; Sayed F Abdelwahab; Ahmed Medhat; Kenneth E Sherman; Mohamed Tarek M Shata
Journal:  Arch Virol       Date:  2016-08-20       Impact factor: 2.574
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.